Literature DB >> 17366373

Antiproliferative cardenolides from Periploca graeca.

Daniela Spera1, Tiziana Siciliano, Nunziatina De Tommasi, Alessandra Braca, Anne Vessières.   

Abstract

Nine cardiotonic steroids, six 17beta-cardenolides (2, 4, 6-9) and three 17alpha-cardenolides (1, 3, 5) have been identified from the chloroform and chloroform-methanol extracts of Periploca graeca L. (Asclepiadaceae) stems. Among these, compound 5, the 17alpha-isomer of periplocin 6, was identified as a new compound. The antiproliferative effects of these compounds were tested in vitro in the hormone-independent prostate cancer cell line PC-3. Five of these compounds, all 17beta-isomers with a 14beta-OH group and at least one sugar molecule (4, 6-9), showed a very strong antiproliferative effect, with IC50 values between 18 and 50 nM. Compound 2, the only 17beta-cardenolide aglycone, had an IC50 value of 0.6 microM, which is 13 to 16 times higher than the values found for the corresponding cardenolides with one or two sugars. The IC50 values found for the three 17alpha-isomers were significantly higher (5.4 and 7.3 microM), with IC50 ratios (17alpha-cardenolide/17beta-cardenolide) of up to 192. In the 17alpha-cardenolide series, the presence of a sugar unit does not seem to have a significant effect on the IC50 values. This is the first report showing a markedly different cytotoxicities between the 17alpha- and 17beta-isomers in the cardenolide series.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17366373     DOI: 10.1055/s-2007-967133

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

1.  Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3.

Authors:  Yamei Hu; Fangfang Liu; Xuechao Jia; Penglei Wang; Tingxuan Gu; Hui Liu; Tingting Liu; Huifang Wei; Hanyong Chen; Jiuzhou Zhao; Ran Yang; Yingying Chen; Zigang Dong; Kangdong Liu
Journal:  Oncogene       Date:  2021-05-13       Impact factor: 9.867

2.  Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation.

Authors:  Hui-Yun Zhang; Wen-Qian Xu; Yuan-Yuan Zheng; Emmanuel Omari-Siaw; Yuan Zhu; Xia Cao; Shan-Shan Tong; Jiang-Nan Yu; Xi-Ming Xu
Journal:  Oncotarget       Date:  2016-12-27

Review 3.  Oleandrin: A cardiac glycosides with potent cytotoxicity.

Authors:  Arvind Kumar; Tanmoy De; Amrita Mishra; Arun K Mishra
Journal:  Pharmacogn Rev       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.